Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Outcomes of Hypertension in Obese Versus Non-obese Pregnant Women
Sponsor: Assiut University
Summary
Hypertensive disorders of pregnancy, include pre-existing and gestational hypertension, preeclampsia, and eclampsia, it complicates up to 10% of pregnancies and represents a significant cause of maternal and perinatal morbidity and mortality. Following the "National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy" recommendation is currently a systolic blood pressure (SBP) ⩾ of 140 mmHg and diastolic blood pressure (DBP) ⩾ of 90 mmHg. The diagnosis generally requires two separate measurements. Accepted across international guidelines are the following four categories: Chronic/pre-existing hypertension (Hypertension discovered preconception or prior to 20 weeks gestation), Gestational hypertension (Hypertension that appears de novo after 20 weeks gestation and normalizes after pregnancy), Preeclampsia-eclampsia (De novo hypertension after 20 weeks' gestation accompanied by proteinuria, other features of maternal organ dysfunction or uteroplacental dysfunction), Chronic/pre-existing hypertension with superimposed preeclampsia-eclampsia. Over the past 2 decades, extensive epidemiologic studies have clearly established that obesity is a major risk for gestational hypertension and preeclampsia. The risk of preeclampsia typically doubles with each 5-7 kg/m2 increase in pre-pregnancy. The mechanisms have only been partially explored; increased cytokine-mediated inflammation and oxidative stress, increased shear stress, dyslipidemia, and increased sympathetic activity1 have all been proposed as possible pathways. Few studies have examined the relationship between pre-pregnancy BMI, gestational weight gain (GWG), and the risk of preeclampsia. So, our study aims to evaluate the adverse maternal and fetal outcomes related to hypertension in obese and non-obese pregnant women.
Official title: The Differences in Adverse Maternal and Fetal Outcomes Related to Hypertension in Obese Versus Non-obese Pregnant Women
Key Details
Gender
FEMALE
Age Range
25 Years - 35 Years
Study Type
INTERVENTIONAL
Enrollment
260
Start Date
2025-04-01
Completion Date
2026-10
Last Updated
2024-04-24
Healthy Volunteers
No
Conditions
Interventions
Anti-Hypertensive
For control of the blood pressure
Ultrasound
For assessment of gestational age and fetal weight
Doppler ultrasound
Umbilical artery Doppler assessment
complete blood count
For assessment of platelet count
Body mass index
for assessment of maternal weight during pregnancy
Locations (1)
Women Health Hospital - Assiut university
Asyut, Egypt